The representative of profiteering from the sale of foreign traditional Chinese medicine suggests restricting the export of traditional Chinese Medicine

"Some foreign traditional Chinese medicines originated from the ancient Chinese recipe, for example, the ancient Chinese recipe Liushen Pill increases the cost of Shenmai and Chenxiang to make Jiuxin Pill, which is several times or even dozens of times higher than us, which is very unfavorable to the development of Chinese medicine in China." Li Zhenjiang, deputy to the National People's Congress and President of Shenwei Pharmaceutical Group, suggested that the state should restrict the export of raw materials and extracts of traditional Chinese medicine, vigorously support the innovation of national pharmaceutical industry, improve the added value of product science and technology, and enhance the competitiveness of the international market In the export of Chinese herbal medicines, most of them are raw materials, less than 4% of them are finished products "Some foreign pharmaceutical enterprises import Chinese herbal extracts from China After deep processing in foreign countries, adding a foreign language becomes a" foreign Chinese medicine ", which is actually a copy of the domestic Chinese medicine." Li Zhenjiang pointed out that the price of "foreign traditional Chinese medicine" is several times, even dozens of times higher than that in China And hospitals like to use expensive drugs, which provides convenience for "foreign traditional Chinese medicine" to enter the domestic market Li Zhenjiang suggested that the state should enact relevant legislation as soon as possible, and support the Chinese medicine industry of the motherland to become stronger and bigger in terms of national policies, capital investment, personnel training, etc He said that the state should support enterprises to increase their ability of independent innovation and constantly launch new products suitable for the changes of social diseases In case of major epidemics or sudden emergency drug use, China will not be subject to transnational pharmaceutical groups and their "foreign drugs" to ensure the national medical security.